Outcome of the Board Meeting held on Saturday, 30 May, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Caprolactam Chemicals Ltd reported strong financial performance for FY 2025-26 with total income of Rs. 1,058.86 lakhs, up 57% from Rs. 674.92 lakhs in the previous year. The company turned profitable with profit after tax of Rs. 176.12 lakhs compared to a loss of Rs. 70.87 lakhs in FY25. EPS improved from Rs. -1.54 to Rs. 3.83. Operating cash flow turned positive at Rs. 164.97 lakhs from negative Rs. 56.18 lakhs. The statutory auditor issued an unmodified (clean) opinion. The board also appointed M/s. Shrey Pandey & Associates as internal auditor for FY 2026-27. Borrowings increased significantly to Rs. 922.90 lakhs from Rs. 371.34 lakhs previously.
The company has shown a remarkable turnaround from losses to profits with strong revenue growth, which is positive for shareholders. However, the significant increase in borrowings warrants monitoring for debt sustainability.